Pzena Investment Management LLC Acquires 469,581 Shares of Amdocs Limited $DOX

Pzena Investment Management LLC increased its holdings in shares of Amdocs Limited (NASDAQ:DOX) by 3.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 14,454,911 shares of the technology company’s stock after buying an additional 469,581 shares during the period. Amdocs comprises 2.5% of Pzena Investment Management LLC’s investment portfolio, making the stock its 16th largest holding. Pzena Investment Management LLC owned approximately 13.39% of Amdocs worth $826,532,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the business. Royal Bank of Canada increased its position in shares of Amdocs by 14.9% in the 1st quarter. Royal Bank of Canada now owns 446,125 shares of the technology company’s stock valued at $29,114,000 after purchasing an additional 57,740 shares during the last quarter. Renaissance Technologies LLC raised its holdings in shares of Amdocs by 429.6% in the 1st quarter. Renaissance Technologies LLC now owns 291,800 shares of the technology company’s stock valued at $19,043,000 after purchasing an additional 236,700 shares in the last quarter. Arbejdsmarkedets Tillaegspension lifted its position in shares of Amdocs by 17.5% during the 1st quarter. Arbejdsmarkedets Tillaegspension now owns 354,383 shares of the technology company’s stock worth $23,127,000 after purchasing an additional 52,906 shares during the last quarter. Steel Grove Capital Advisors LLC purchased a new stake in shares of Amdocs during the 3rd quarter worth $2,229,000. Finally, TD Waterhouse Canada Inc. grew its stake in shares of Amdocs by 14.1% during the second quarter. TD Waterhouse Canada Inc. now owns 247,521 shares of the technology company’s stock worth $12,682,000 after purchasing an additional 30,555 shares in the last quarter. 92.02% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on DOX shares. Oppenheimer lowered shares of Amdocs from an “outperform” rating to a “market perform” rating in a research note on Wednesday. Stifel Nicolaus decreased their price objective on shares of Amdocs from $71.00 to $46.00 and set a “buy” rating for the company in a research note on Wednesday. Weiss Ratings raised Amdocs from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, October 23rd. Finally, Wall Street Zen upgraded Amdocs from a “hold” rating to a “buy” rating in a research report on Saturday, August 29th. Three equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $78.33.

More Amdocs News

Here are the key news stories impacting Amdocs this week:

• Positive Sentiment: Amdocs announced an expanded collaboration with AT&T, which could support longer-term business opportunities. AT&T and Amdocs Expand Collaboration
• Positive Sentiment: The company agreed to acquire insurance software provider EIS for $340 million, a move that could diversify its business, though integration and execution risks remain. Amdocs acquires insurance tech firm EIS for $340 million
• Neutral Sentiment: Fiscal Q4 adjusted EPS of $1.98 and revenue of $1.19 billion matched analyst estimates; revenue grew 3.8% year over year. The in-line results offered little offset to concern about the outlook. Amdocs Meets Q4 Earnings Estimates
• Negative Sentiment: The T-Mobile contract dispute is the main catalyst for the selloff. Amdocs’ fiscal 2027 outlook reportedly allows for revenue to fall as much as 18%, including the possibility that its T-Mobile agreements end. Management has not detailed the company’s revenue exposure to T-Mobile, adding uncertainty. Amdocs Stock Has Its Worst Day in 24 Years as T-Mobile Business Is at Risk
• Negative Sentiment: Several law firms announced investigations into potential securities-law violations related to alleged misrepresentations about the T-Mobile relationship. These are allegations under investigation, not findings of wrongdoing, but could add legal and reputational risk. Hagens Berman investigation
• Negative Sentiment: Analyst actions added pressure: Oppenheimer downgraded the stock to Perform, while Stifel cut its price target from $71 to $46, despite retaining a Buy rating.

Amdocs Stock Performance

NASDAQ DOX opened at $43.66 on Thursday. Amdocs Limited has a fifty-two week low of $41.44 and a fifty-two week high of $85.63. The stock has a market cap of $4.71 billion, a price-to-earnings ratio of 9.42, a price-to-earnings-growth ratio of 1.00 and a beta of 0.42. The business has a fifty day moving average of $60.27 and a 200-day moving average of $62.38. The company has a quick ratio of 0.94, a current ratio of 0.94 and a debt-to-equity ratio of 0.23.

Amdocs (NASDAQ:DOX) last released its earnings results on Tuesday, November 3rd. The technology company reported $1.98 earnings per share for the quarter, hitting the consensus estimate of $1.98. The firm had revenue of $1.19 billion for the quarter, compared to the consensus estimate of $1.19 billion. Amdocs had a return on equity of 20.70% and a net margin of 10.59%. The firm’s revenue for the quarter was up 3.8% compared to the same quarter last year. During the same period in the prior year, the business posted $1.83 earnings per share. As a group, analysts predict that Amdocs Limited will post 7.12 earnings per share for the current fiscal year.

Amdocs Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 29th. Stockholders of record on Thursday, December 31st will be paid a dividend of $0.5690 per share. The ex-dividend date is Thursday, December 31st. This represents a $2.28 annualized dividend and a dividend yield of 5.2%. Amdocs’s dividend payout ratio (DPR) is currently 54.29%.

Amdocs Profile

Amdocs Ltd. (NASDAQ: DOX) is a global provider of software and technology services for communications, media and entertainment companies. Its solutions help service providers manage customer relationships, billing, subscriptions, product offerings and digital experiences across consumer and enterprise markets.

The company’s portfolio includes business support systems and operational support systems, cloud-based software, artificial intelligence and automation tools, network and service management platforms, and solutions for media distribution and monetization.